To investigate the role of the tandem BRCT motifs of Rad9, they were mutated as indicated in Figure 1a . A carboxy-terminally truncated Rad9 protein (Rad9∆CT), which lacks the BRCT domain, was expressed under the control of a galactose-inducible (GAL) promoter in a rad9∆ (null) yeast strain. We observed that Rad9∆CT was substantially less able to complement survival of the rad9∆ strain after UV irradiation than wild-type RAD9, demonstrating that the BRCT domain is critical for Rad9 function (Figure 1b) . Site-directed mutagenesis was used to alter an aromatic residue in each BRCT motif (Figure 1a) . This residue, which is F1104 (in the singleletter amino acid code) in the first BRCT motif of Rad9 (BRCTa) and W1280 in the second (BRCTb), has been described as the most highly conserved residue of the BRCT motif [2, 3] . We replaced this residue with leucine in order to maintain hydrophobicity. The mutant proteins were expressed under the control of the GAL promoter in rad9∆ cells. Induced levels of both wild-type and pointmutated Rad9 were about 100-fold above the level of endogenous Rad9, whereas the level of Rad9∆CT was about 20-fold above (See Supplementary material published with this article on the internet). In all cases, survival after UV irradiation was reduced relative to cells expressing wild-type RAD9 (Figure 1b) . Mutations in BRCTb alone (rad9 W ) or in both BRCT motifs (rad9 F+W ) mimicked rad9∆CT, demonstrating a more dramatic phenotype than the mutation of BRCTa alone (rad9 F ).
Results and discussion
To investigate the role of the tandem BRCT motifs of Rad9, they were mutated as indicated in Figure 1a . A carboxy-terminally truncated Rad9 protein (Rad9∆CT), which lacks the BRCT domain, was expressed under the control of a galactose-inducible (GAL) promoter in a rad9∆ (null) yeast strain. We observed that Rad9∆CT was substantially less able to complement survival of the rad9∆ strain after UV irradiation than wild-type RAD9, demonstrating that the BRCT domain is critical for Rad9 function (Figure 1b) . Site-directed mutagenesis was used to alter an aromatic residue in each BRCT motif ( Figure 1a ). This residue, which is F1104 (in the singleletter amino acid code) in the first BRCT motif of Rad9 (BRCTa) and W1280 in the second (BRCTb), has been described as the most highly conserved residue of the BRCT motif [2, 3] . We replaced this residue with leucine in order to maintain hydrophobicity. The mutant proteins were expressed under the control of the GAL promoter in rad9∆ cells. Induced levels of both wild-type and pointmutated Rad9 were about 100-fold above the level of endogenous Rad9, whereas the level of Rad9∆CT was about 20-fold above (See Supplementary material published with this article on the internet). In all cases, survival after UV irradiation was reduced relative to cells expressing wild-type RAD9 (Figure 1b) . Mutations in BRCTb alone (rad9 W ) or in both BRCT motifs (rad9 F+W ) mimicked rad9∆CT, demonstrating a more dramatic phenotype than the mutation of BRCTa alone (rad9 F ).
Overexpression of checkpoint genes, including RAD9, can modify the checkpoint response [7] . We therefore produced integrative mutants in order to test the mutated Rad9 proteins at normal levels of expression. We replaced the 3′ end of wild-type RAD9 by targeted integration of sequences encoding the different mutations. The rad9∆CT, rad9 W and rad9 F+W strains had survival rates after UV irradiation as low as rad9∆ (Figure 2a ). The rad9 W mutant survived slightly better than the other mutant strains. Also, the rad9 F+W strain was tested for its ability to arrest at the G2 checkpoint after UV irradiation. A deficiency in arrest at the G2 checkpoint similar to that of the rad9∆ control was observed (Figure 2b ). Western-blot analysis of the mutant Rad9 proteins demonstrated levels of expression equivalent to wild-type Rad9, except for Rad9∆CT, which was consistently expressed at 2-3-fold lower levels ( Figure 2c ). Rad9 is normally hyperphosphorylated after DNA damage, and this coincides with checkpoint arrest [4] [5] [6] . In contrast to wild-type cells, none of the rad9 BRCT mutants displayed any hyperphosphorylation after DNA damage (Figure 2c ) or methyl methane-sulphonate (data not shown). Although it is possible that critical phosphorylation sites could be located within the BRCT domain of Rad9, and therefore could be missing when this domain is deleted, the absence of hyperphosphorylation after DNA damage in rad9 point mutants showed that this phenomenon was not simply due to the loss of phosphorylation sites.
Rad53 functions downstream of Rad9 in the checkpoint pathway [8, 9] and some Rad53 interacts with the hyperphosphorylated forms of Rad9 after DNA damage [4] [5] [6] . Western-blot analysis of the mutants demonstrated that no Rad9-dependent phosphorylation of Rad53 occurred in the BRCT rad9 mutants after DNA damage (Figure 2c ).
Together, these results demonstrate that the BRCT domain of Rad9 has a critical role in the Rad9-dependent activation of the DNA damage checkpoint pathway. Because BRCT domains are likely to mediate protein-protein interaction, a two-hybrid approach was used to identify binding partners of this domain using the complete Rad9 BRCT domain fused to the GAL4 DNAbinding domain (BRCT-BD). Unlike the related BRCT domain of BRCA1, the Rad9 BRCT-BD fusion protein did not itself activate the β-galactosidase reporter gene used in the assay. An interaction between the Rad9 BRCT-BD and the Rad9 BRCT domain fused to the GAL4 activation domain (BRCT-AD) was identified (Figure 3a) . BRCT-BD also interacted with full-length Rad9 fused to the GAL4 activation domain (Rad9-AD). In contrast, the mutated BRCT F+W -BD fusion protein failed to interact with BRCT-AD and Rad9-AD. Using this system we also tested other candidate proteins for interaction with the Rad9 BRCT: the other BRCT-containing proteins of S. cerevisiae [2, 3] , because interactions between BRCT domains of different proteins have been reported [10] [11] [12] ; Rad53, which has been shown to interact with Rad9 [4] [5] [6] ; and Dpb11 (which also contains BRCT domains) and the protein encoded by YBR274w, which share sequence homology with the Schizosaccharomyces pombe Cut5/Rad4 and Chk1 checkpoint proteins, respectively, and which both interact with Crb2, an S. pombe checkpoint protein related to Rad9 [11] . With the exception of Rad9 itself, 552 Current Biology, Vol 9 No 10
Figure 2
The effects of normal levels of expression of the BRCT-mutated Rad9 proteins on survival, the G2/M checkpoint and hyperphosphorylation after damage. (a) Sensitivity to UV of the mutant proteins expressed at levels equivalent to the wild-type Rad9 protein. Error bars were omitted for clarity but consistent results were obtained from at least three experiments. (b) G2-checkpoint phenotype analysis of the rad9 F+W mutant. Cells that arrest at the G2 checkpoint are large, budded and with a single nucleus. Error bars have been omitted for clarity, but standard deviations from at least three experiments were < 5% in all cases. (c) Western-blot analysis of the Rad9 and Rad53 proteins in non-irradiated and UV-irradiated cells. The BRCT mutants were grown to exponential phase and either mock-treated or UV-irradiated (50 J/m 2 ). The resulting protein extracts were blotted and probed with anti-Rad9 and anti-Rad53 antisera. P-Rad9 and P-Rad53 indicate the hyperphosphorylated forms of Rad9 and the phosphorylated forms of Rad53, respectively. The Rad9 BRCT-BRCT interaction was biochemically analysed using glutathione-S-transferase (GST) fusion proteins and differentially tagged Rad9 proteins. A GST-BRCT fusion protein, but not GST-BRCT F+W , could bind bacterially expressed T7-tagged Rad9, demonstrating a direct BRCT-BRCT interaction (Figure 3b ). The GST-BRCT fusion protein consistently bound the hyperphosphorylated forms of Rad9 from extracts of wild-type, DNA-damaged yeast cells (Figure 3c ). Strikingly, it was also able to preferentially bind a small amount of hyperphosphorylated Rad9 from extracts prepared from non-damaged cells (Figure 3c ). This presumably reflects residual low levels of endogenous damage that are not normally detected by western blot. In contrast, the GST-BRCT F+W fusion protein failed to bind hyperphosphorylated forms of Rad9 from UV-irradiated or non-irradiated cell extracts ( Figure  3c ). Relative to a low background of non-specific binding of Rad9 to GST (also seen in [5] ), some of the faster-migrating (hypophosphorylated) forms of Rad9 were also bound by GST-BRCT and GST-BRCT F+W . When compared with the relative amounts of hypo-and hyperphosphorylated Rad9 present in the input extracts, this interaction appeared to be weaker than with the hyperphosphorylated Rad9. Moreover, this aromatic-residue-independent interaction with hypophosphorylated Rad9 was more salt-sensitive than the aromatic-residue-dependent interaction with hyperphosphorylated Rad9 (data not shown).
These in vitro results were confirmed in vivo using diploid strains that simultaneously expressed, at normal levels, two differentially tagged Rad9 proteins (Figure 3d ). Rad9 proteins bearing three haemagglutinin (HA) tags (HA 3 -Rad9) copurified with ten-histidine (His 10 )-tagged Rad9 (His 10 -Rad9) proteins when they were affinity purified on nickel-agarose beads. Full-length His 10 -Rad9 interacted with the most hyperphosphorylated forms of HA 3 -Rad9 present after DNA damage with greater affinity than with hypophosphorylated forms (Figure 3d, top  panel) . Copurification of hyperphosphorylated HA 3 
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Figure 3
Analysis of BRCT-mediated Rad9-Rad9 interaction. (a) Two-hybrid analysis of the interaction of the Rad9 BRCT domain with itself and with full-length Rad9. β-galactosidase activity was tested on the mated strains as indicated: BRCT-BD and BRCT F+W -BD, the wild-type and mutated Rad9 BRCT domains, respectively, fused to BD; BRCT-AD and Rad9-AD, the Rad9 BRCT and full-length Rad9, respectively, fused to AD; p53-BD, p53 protein fused to BD; SV40-AD, simian virus 40 (SV40) large T antigen fused to AD; Laminin-BD, laminin fused to BD. The lack of interaction between laminin and any AD fusion serves as a negative control. The positive control is the interaction of the p53 protein with the SV40 large T antigen. was abolished when His 10 -Rad9 F+W was used. In the absence of DNA damage, hypophosphorylated HA 3 -Rad9 weakly interacted with wild-type or mutant His 10 -Rad9, showing that in this case the interaction was independent of the aromatic residues. Together, these data suggest that, although a fraction of Rad9 interacts with itself in undamaged cells, perhaps through a non-BRCT domain, after DNA damage an interaction between Rad9 BRCT domains occurs with greater affinity. This DNA-damagedependent interaction requires the conserved aromatic residues of the BRCT domain, mutation of which results in a rad9∆ phenotype, suggesting that a BRCT-domainmediated oligomerization is required for Rad9 function.
Interactions between BRCT domains of different proteins have been demonstrated for XRCC1, which interacts though its carboxy-terminal BRCT domain with the BRCT domain of ligase III-α [11, 13] , and through its amino-terminal BRCT domain with the BRCT domain of PARP [12] . Additionally, the amino-terminal BRCT domain of the S. pombe Cut5/Rad4 protein interacts with Crb2, which also contains a BRCT tandem motif in its carboxyl terminus [11] . Our results are consistent with the finding that the carboxy-terminal BRCT domain of XRCC1 homodimerizes in the recently reported crystal structure [14] . The absence of any identifiable interaction with other S. cerevisiae BRCTdomain proteins (see Supplementary material) highlights the specificity of the Rad9 BRCT-BRCT interaction, but it does not exclude the possibility that this domain may also interact with other proteins.
The rad9 null phenotypes observed for the rad9 BRCT mutants demonstrate that the BRCT domain is essential for Rad9's normal function. The Rad9-Rad9 interaction occurred with a much greater affinity when Rad9 was hyperphosphorylated and was inhibited by the BRCT point mutations. Together, these data suggest that oligomerization of Rad9 is regulated by DNA damage and is required for the DNA-damage-checkpoint response. Overexpression of the mutant proteins partially rescued the rad9 null phenotype, perhaps overcoming by protein dosage their failure to oligomerize. Hyperphosphorylated forms of Rad9 also interact with the second forkheadhomology-associated domain of Rad53 [5] . The Rad53-binding domain of Rad9 is located upstream from the BRCT domain [5] . It is likely that, after DNA damage, a high-molecular-weight complex forms, at least transiently, which contains phosphorylated Rad53, hyperphosphorylated Rad9 and perhaps other proteins. This complex may be involved in sensing or processing DNA lesions and/or in transducing the DNA-damage-checkpoint signal.
Our data may be relevant to other proteins with BRCT domains, including the tumour-suppressor protein BRCA1, which also contains tandem BRCT motifs in its carboxyl terminus [2, 3] and is hyperphosphorylated after DNA damage in a manner similar to Rad9 [15] . In addition to numerous nonsense mutations leading to truncated BRCA1, mutation of the conserved tryptophan of the second BRCT motif of BRCA1 (W1708D) has been reported in the BIC database (see www.nhgri.nih.gov/Intramural_research/Lab_transfer/Bic). The phosphorylation state of truncated or point-mutated BRCA1 proteins has not been reported to date.
Supplementary material
Additional details, including construction of mutant strains, plasmids for two-hybrid analysis, GST precipitation analysis, production of diploid strains expressing differentially tagged Rad9 proteins, nickel-agarose chromatography, western analysis of overexpressed Rad9 and addition two-hybrid data are published with this paper on the internet. 
Supplementary materials and methods

rad9 mutations
The YCpIF16-Rad9 construct, which we used to express wild-type RAD9 under the control of a galactose-inducible promoter, has been previously described [S1]. It was deleted or mutated as follows: the carboxy-terminal truncation was achieved by removal of a 502 bp HindIII fragment, resulting in a frameshift which created a stop codon leading to a deletion of the carboxy-terminal 223 residues of Rad9. The site-directed mutations were generated using the QuickChange SiteDirected Mutagenesis Kit (Stratagene) and the primer pairs 5′-CACTACACTGGAAATTGATAAGTGCATGCATTG-3′ and 5′-CAA-TGCATGCACTTATCAATTTCCAGTGTAGTG-3′, for the C3868G mutation that resulted in the F1104L substitution in BRCTa; 5′-CAC-TGAATCTAAAGAATTGCTAATTCAGACAATAATTAACG-3′ and 5′-CGTTAATTATTGTCTGAATTAGCAATTCTTTAGATTCAGTG-3′, for the G4396T mutation that resulted in the W1280L substitution in BRCTb. Mutated bases are underlined.
Replacement of the endogenous RAD9 with the rad9 mutations
The 1230 bp 3′ regions of the wild-type or mutated rad9 genes were amplified using primers 5′-CGCGGATCCGCTAAAAGAGCGAAG ATC-A-3′ and 5′-CGCGGATCCTCATCTAACCTCAGAAATAG-3′, and the resulting fragments were cloned into the BamHI site of the pRS303 integration vector from which the SacI site had been destroyed by SacI digestion, filling in with Pfu polymerase and re-ligation. The constructs were integrated into the RAD9 locus of the W303-1a strain after SacI linearization, leading to replacement of the last 1048 nucleotides of the RAD9 gene. Correct integration was checked for all mutants by genomic PCR .
Two-hybrid system
A 978 bp 3′ terminal fragment of the RAD9 gene encoding the BRCT motifs was amplified between the primers 5′-CATGCCATGGGTGAA-ATCAGAACAGGG-3′ and 5'-CGCGGATCCTCATCTAACCTCAGA-AATAG-3′ and cloned between the NcoI and BamHI sites of the pAS1-CYH2 vector in order to produce the BRCT-BD bait fusion protein. This construct was point-mutated as described above in order to produce the mutant fusion protein BRCT F+W -BD. The wild-type BRCT-domain-encoding fragment and the full-length RAD9 gene were cloned in frame in the pACT2 vector (Clontech), as well as the other BRCT-protein-encoding S. cerevisiae genes (Table 1) , and the RAD53 and YBR274w genes. All PCR reactions were performed using the Pfu high-fidelity DNA polymerase (Stratagene) and the resulting fragments were cloned into the pACT2 vector.
GST binding assay
The wild-type and mutated BRCT 978 bp 3′ terminal fragments of the RAD9 gene used for the two-hybrid test were subcloned into the pRP261 vector (a pGEX3 derived vector). The GST-BRCT and GST-BRCT F+W fusion proteins were produced in bacteria by 2 h growth in 0.4 mM IPTG at 30°C. The wild-type 978 bp 3′ terminal fragment of RAD9 was also cloned in the pET21a vector (Novagen) in frame with the T7 tag sequence in order to produce the amino-terminal T7-tagged BRCT fusion protein. Bacterially expressed extracts were incubated for 4 h at 4°C with the GST fusion proteins bound to glutathione-Sepharose beads (Pharmacia). After extensive washes under high-stringency conditions (the wash buffer contained 0.6 M NaCl, 50 mM Tris pH 7.5, 10% glycerol, 0.5% Tween20, 8 mM β-mercaptoethanol, 170 µg/ml phenylmethylsulphonyl fluoride (PMSF), 1 µg/ml leupeptin, 1 µg/ml pepstatin A, 1 µg/ml antipain, 330 µg/ml benzamidine and 50 mM NaF), the beads were boiled in Laemmli buffer and the proteins were revealed by western blotting using the T7 tag monoclonal antibody (Novagen). Yeast protein extracts from UV-irradiated or mock-treated wild-type cells were incubated for 4 h at 4°C with the fusion proteins bound to glutathione-Sepharose beads. After extensive
Supplementary material
Figure S1
Western analysis of the levels of overexpression of wild-type and mutant Rad9 proteins. 10 µg wild-type W303 extracts were compared to 0.1 µg (1/100 dilution) extracts from the mutant strains and controls. Note that overexpression of Rad9 led to a slight decrease in its mobility relative to endogenous Rad9, possibly due to limiting Rad9-directed phosphatase activities. Table S1 Two-hybrid screening of the S. cerevisiae BRCT proteins. The ten S. cerevisiae proteins identified from the yeast genome that contain one or several BRCT motifs in their amino-acid sequences are shown [2, 3] . Nine of the ten were tested using the two-hybrid system for an interaction with the Rad9 BRCT domain. A specific interaction with Rad9 itself (see Figure 3a) but not with the other proteins listed was demonstrated. As negative controls, the interaction of each protein with p53 and laminin was measured. nd, not determined.
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